AbbVie (ABBV) Income from Non-Controlling Interests (2020 - 2026)

AbbVie has disclosed Income from Non-Controlling Interests across 7 years of filings, most recently posting $2.0 million for Q1 2026.

• In Q1 2026, Income from Non-Controlling Interests fell 33.33% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $6.0 million (down 25.0% YoY), while the FY2025 annual figure was $7.0 million, down 12.5% from the prior year.
• Income from Non-Controlling Interests improved to $2.0 million in Q1 2026, from -$1.0 million in the prior quarter.
• Over the last five years, Income from Non-Controlling Interests for ABBV reached as high as $4.0 million in Q2 2022 and fell as low as -$1.0 million in Q4 2022.
• The 5-year median for Income from Non-Controlling Interests is $3.0 million (2022), against an average of $2.1 million.
• Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests slumped 200.0% — and 2023, when it soared 300.0%.
• A 5-year view of Income from Non-Controlling Interests shows it stood at -$1.0 million in 2022, then soared by 300.0% to $2.0 million in 2023, then tumbled by 150.0% to -$1.0 million in 2024, then changed by 0.0% to -$1.0 million in 2025, then soared by 300.0% to $2.0 million in 2026.
• According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $2.0 million, -$1.0 million, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.